Google
ARAY Stock Price & Analysis — Accuray Incorporated (Healthcare >> Medical Devices)
ARAY FAQ
What is ARAY's P/E ratio?
Accuray Incorporated (ARAY) currently trades at a P/E ratio of 30.31.
What is ARAY's ROE?
Accuray Incorporated reports a Return on Equity (ROE) of -110.60%.
What is ARAY's dividend yield?
Accuray Incorporated offers a dividend yield of 0.00%.
What is ARAY's Quality Score?
Our AI rates ARAY's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ARAY?
Our AI Timing Score for ARAY is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ARAY belong to?
Accuray Incorporated is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
ARAY AI Analysis Summary
Our AI summary for ARAY: Accuray Incorporated (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 30.31, ROE of -110.60%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.27
Price
-0.02
(-5.93%)
Day Change
|
|
|---|
ARAY, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.27 |
| PBV / Sector |
0.82 / -101.57
GREAT
|
| Earning Per Share | -0.36 |
| PE / Sector |
30.31 / 31.23
|
| PEG or PE/Growth / Sector |
2.27 / 0.40
|
| Average 1M Daily Value |
0.37 M
GREAT
|
| Average 1W Daily Value |
0.71 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 07:59:29 |
| Symbol | ARAY |
| Name | ACCURAY INCORPORATED |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 119.43 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 34.04 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1240 Deming Way, Madison, WI, United States, 53717-1954
Phone: 608 824 2800
Website: https://www.accuray.com
Employees: 990
Sector: Healthcare >> Medical Devices
Description: Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
